Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3015479	b-tbevi	— (—)	587	932	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Fever of other and unknown origin

261

174

14.01

272.25

1.7

1.4

—

Bacterial infection, other or unspecified

248

160

14.10

255.26

1.7

1.5

—

Other bacterial diseases

321

222

10.05

231.65

1.7

1.5

—

Primary_lymphoid and hematopoietic malignant neoplasms

152

17.31

184.93

1.8

1.6

—

Primary_lymphoid and hematopoietic malignant neoplasms

152

121

12.73

156.35

1.8

1.6

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

274

294

6.71

149.64

1.7

1.5

—

Other septicaemia

135

110

12.13

133.73

1.7

1.5

—

Septicaemia

142

125

10.99

130.64

1.7

1.5

—

Pneumonias (Asthma/COPD co-morbidities)

253

293

6.00

123.22

1.7

1.5

—

All pneumoniae

252

298

5.85

119.72

1.7

1.5

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

230

219

6.60

116.16

1.7

1.5

—

230

219

6.60

116.16

1.7

1.5

—

Pneumonia, organism unspecified

233

284

5.95

114.89

1.7

1.4

—

ILD medications: immunosuppressive drugs

174

237

7.07

113.64

1.9

1.4

—

Influenza and pneumonia

249

292

5.62

111.37

1.7

1.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

242

308

5.54

109.84

1.7

1.4

—

Infections, IBD-co-morbidities

21.40

102.91

2.1

1.6

—

Explicit Sepsis

147

189

7.50

101.07

1.7

1.5

—

Certain infectious and parasitic diseases

192

129

7.47

94.42

1.7

1.3

—

ILD medications: prednisolone, methylprednisolone, prednisone

241

269

5.08

90.91

1.7

1.4

—

ILD medications

243

271

4.93

87.88

1.8

1.4

—

First line medication for Crohn's disease

233

250

5.10

86.82

1.7

1.5

—

Aplastic and other anaemias

143

214

6.37

84.38

1.6

—

General symptoms and signs

220

202

5.47

84.16

1.7

1.4

—

Transplanted organ and tissue status

16.32

81.36

2.1

1.6

—

Oral corticosteroids

231

316

4.43

77.70

1.7

1.5

—

Other anaemias

132

205

6.25

76.97

1.6

—

Other and unspecified anaemias

131

203

6.28

76.84

1.6

—

Bacterial Sepsis

134

190

6.31

76.37

1.7

1.5

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

14.33

74.98

1.8

1.4

—

Implicit bacterial Sepsis

123

173

6.55

73.61

1.7

1.5

—

GASTRO-related operations

127

9.25

71.93

1.6

1.2

—

Any gastric operation

127

9.25

71.93

1.6

1.2

—

Other diseases of blood and blood-forming organs, wide

107

8.58

71.23

1.8

1.5

—

Inflammatory bowel disease treatment related agents

231

321

4.10

68.98

1.7

1.5

—

Renal tubulo-interstitial diseases

189

337

4.31

67.47

1.6

1.5

—

Enlarged lymph nodes

13.17

67.31

1.8

1.4

—

Anaemias

17.18

66.62

1.9

1.8

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

28.42

64.98

2.2

1.2

—

Myeloid leukaemia

36.98

62.21

1.8

1.4

—

Non-follicular lymphoma, hilmo, excluding all cancers

15.06

58.82

1.8

1.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

152

341

4.14

55.00

1.7

1.5

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

183

335

3.72

51.81

1.7

1.5

—

Myeloid leukaemia

21.39

51.59

1.8

1.5

—

COPD/asthma/ILD related infections

178

219

4.08

50.25

1.8

1.5

—

COPD/asthma related infections

178

219

4.08

50.25

1.8

1.5

—

Abnormal findings on diagnostic imaging of lung

124

274

4.42

49.60

1.7

1.6

—

Malignant neoplasm, wide definition for exclusion

163

236

4.09

49.58

1.6

1.5

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

163

236

4.09

49.57

1.6

1.5

—

Autoimmune diseases related-to ILD

163

390

3.68

49.48

1.7

1.5

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

162

236

4.07

48.91

1.6

1.5

—

Nephropathy related operations

8.88

46.65

1.9

1.6

—

Implicit Sepsis

142

283

3.91

45.10

1.7

1.5

—

Renal failure

115

239

4.42

45.02

1.6

—

Dialysis, with operation codes

8.47

44.17

1.9

1.6

—

Systemic connective tissue disorders

181

5.11

44.11

1.5

1.6

—

Lymphoid leukaemia

15.47

43.46

1.8

1.2

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

29.82

43.34

2.3

1.2

—

Malignant neoplasm

160

260

3.66

42.24

1.6

—

Heart failure, not strict

159

313

3.51

41.79

1.6

1.5

—

Tuberculosis, IBD comorbidity

9.74

41.28

2.0

1.3

—

L04AX Other immunosuppressants

114

284

4.02

40.73

1.9

1.6

—

Persons encountering health services for specific procedures and health care

185

362

3.17

40.28

1.6

1.5

—

Second line medication for Crohn's disease

115

292

3.95

40.03

1.9

1.6

—

Non-follicular lymphoma

8.36

39.83

1.8

1.3

—

Tuberculosis, wide

9.18

39.53

2.0

1.3

—

Complications of surgical and medical care, not elsewhere classified

173

395

3.15

39.00

1.8

1.5

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

10.13

38.95

1.5

1.4

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

152

4.99

38.46

1.7

1.6

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

8.79

38.38

1.9

1.7

—

Acute renal failure

110

6.04

37.86

1.6

—

Other pulmonary diagnosis

119

136

4.39

36.74

1.7

1.5

—

Chronic kidney disease

163

4.91

36.65

1.6

—

Agranulocytosis

8.60

36.10

1.6

1.2

—

Excluding asthma or asthma-COPD overlap

118

136

4.35

36.10

1.7

1.5

—

COPD differential diagnosis

118

136

4.35

36.10

1.7

1.5

—

L04AD Calcineurin inhibitors

8.33

35.95

2.4

1.6

—

Other heart diseases

120

4.97

35.91

1.4

1.6

—

ILD differential diagnosis

117

136

4.32

35.46

1.7

1.5

—

Condition for Implicit Sepsis (Organ dysfunction codes)

143

313

3.32

35.36

1.7

1.5

—

Care involving dialysis

11.34

35.36

1.8

1.7

—

Implicit viral Sepsis

6.87

35.12

2.0

1.6

—

Viral Sepsis

6.79

34.72

2.0

1.6

—

Acute myeloid leukaemia and myelodysplastic syndromes

23.60

34.25

2.2

1.4

—

Any event in cancer register

150

273

3.26

33.76

1.6

—

Other heart diseases, wide

144

271

3.30

33.49

1.5

1.6

—

Lymphoid leukaemia

9.91

33.03

1.8

1.3

—

Autoimmune diseases excluding thyroid diseases

174

326

2.97

32.90

1.7

1.5

—

Cytomegalovirus infection, IBD co-morbidity

22.48

32.30

3.2

1.4

—

Cytomegaloviral disease

22.45

32.29

3.2

1.5

—

Other necrotizing vasculopathies

9.39

31.83

1.4

—

Other/unspecified cytomegaloviral diseases

23.81

31.59

3.3

1.6

—

Respiratory tuberculosis, confirmed

23.72

31.58

1.7

1.2

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

23.69

31.57

1.7

1.2

—

L04AA Selective immunosuppressants

113

5.43

31.37

2.5

1.5

—

Autoimmune diseases excluding thyroid diseases, strict definition

167

317

2.94

31.18

1.7

1.4

—

Asthma, unspecified (mode), excluding more controls

105

5.17

30.89

1.5

1.3

—

Atrial fibrillation and flutter

5.12

30.76

1.4

1.6

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

11.26

30.60

1.7

1.3

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

18.91

30.06

1.8

1.3

—

Chronic lymphocytic leukaemia, helper endpoint

18.91

30.06

1.8

1.3

—

Tuberculosis

8.40

30.01

2.0

1.3

—

Complications of medical and surgical care

128

397

3.07

29.98

1.8

1.6

—

Fungal Sepsis

15.58

29.73

2.3

1.5

—

Malaise and fatigue

142

4.47

29.49

1.7

1.4

—

ILD medications: azathioprine

9.01

28.57

2.0

1.3

—

Secondary and unspecified malignant neoplasm of lymph nodes

7.88

28.52

1.7

1.4

—

Diffuse large B-cell lymphoma, helper endpoint

11.80

28.32

1.8

1.2

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

11.80

28.32

1.8

1.2

—

Cardiac arrhythmias

170

3.78

28.03

1.5

1.6

—

Purpura and other haemorrhagic conditions

6.35

27.76

1.5

—

Oxycodone

201

3.91

27.69

1.6

—

Chronic periapical parodontitis

105

5.26

27.40

1.6

—

Implicit fungal Sepsis

15.28

27.14

2.3

1.5

—

Polyarthropathies

125

270

3.09

26.96

1.8

1.6

—

Asthma, unspecified (mode)

121

4.53

26.76

1.5

1.3

—

Erysipelas

180

3.96

26.73

1.4

1.5

—

Pneumonia due to other infectious organisms, not elsewhere classified

15.62

26.29

1.7

1.3

—

Secondary uncertain malignant neoplasm

5.94

26.01

1.6

1.4

—

Certain disorders involving the immune mechanism

5.28

26.00

1.7

1.5

—

Heart failure and antihypertensive medication

4.90

25.64

1.6

1.5

—

Asthma, excluding more controls

116

4.05

25.59

1.5

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

5.24

25.57

1.5

1.6

—

Enterocolitis due to Clostridium difficile

6.61

25.08

1.8

1.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

106

346

3.06

25.08

1.8

1.6

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

9.75

25.00

1.7

1.2

—

Autoimmune diseases

167

326

2.62

24.80

1.8

1.5

—

Valvular operations

6.49

24.69

1.3

1.7

—

Reimbursement for rheumatic diseases

304

3.19

24.66

1.8

1.6

—

Other bacterial intestinal infections

5.30

24.60

1.7

1.5

—

Respiratory tuberculosis, confirmed and not-confirmed

8.71

24.55

1.8

1.4

—

Respiratory tuberculosis

8.71

24.55

1.8

1.4

—

Diffuse large B-cell lymphoma

9.52

24.46

1.8

1.5

—

Other diseases of pleura

254

3.29

24.35

1.9

1.5

—

Other viral diseases

136

4.41

24.33

2.0

1.4

—

Thrombocytopenia, unspecified

7.94

24.28

1.4

—

Heart failure,strict

105

240

3.16

24.14

1.6

1.5

—

Azathioprine

7.32

24.14

2.0

1.4

—

Bacterial intestinal infections, IBD co-morbidities

5.30

24.12

1.7

1.4

—

Extracorporeal dialysis

8.48

24.03

1.6

1.4

—

Asthma (mode)

136

3.68

23.76

1.5

—

Neoplasms

102

161

3.40

23.66

1.7

1.4

—

Coagulation defects, purpura and other haemorrhagic conditions

104

4.93

23.62

1.5

1.6

—

Valvular heart disease excluding rheumatic fever

171

3.60

23.55

1.3

1.6

—

Diseases of the skin and subcutaneous tissue

154

290

2.67

23.53

1.8

1.4

—

Chronic lymphocytic leukaemia

11.69

23.19

1.8

1.3

—

Other diseases of pericardium

13.10

22.87

1.2

1.4

—

Asthma (only as main-diagnosis), excluding more controls

116

3.96

22.84

1.5

—

AV-block

5.89

22.78

1.4

—

Diseases of pulp and periapical tissues

190

3.69

22.38

1.9

1.6

—

Non-rheumatic valve diseases

171

3.51

22.19

1.3

1.6

—

Protozoal diseases

13.40

22.02

2.1

1.4

—

Other medical care

210

3.50

21.97

1.6

1.7

—

Asthma

135

3.54

21.90

1.5

—

Other necrotizing vasculopathies (FG)

8.15

21.77

1.4

1.3

—

Complications of procedures, not elsewhere classified

119

385

2.67

21.42

1.7

1.5

—

Used for control exclusion in common control thyroid runs

152

303

2.55

21.42

1.8

1.5

—

Diseases of the respiratory system

121

3.61

21.37

1.6

1.5

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.41

21.35

2.8

1.3

—

ILD, hospital admission 2, with pulmonary infections

7.55

21.21

1.7

1.3

—

Pneumocystosis

16.91

21.20

1.9

1.4

—

Chronic periodontitis

5.68

21.13

1.7

—

Atrial fibrillation and flutter with reimbursement

4.64

21.01

1.5

1.6

—

Asthma (only as main-diagnosis)

135

3.58

20.91

1.5

—

Dental caries

132

4.14

20.55

2.2

1.6

—

Other disorders of white blood cells

9.03

20.33

1.6

1.3

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

15.23

20.23

1.7

1.3

—

Dentinal caries

110

4.45

20.10

2.0

1.6

—

Acute tubulo-interstitial nephritis

267

2.99

20.08

1.6

—

ILD, hospital admissions 3, with pneumonia sepsis

7.03

19.93

1.7

1.3

—

All influenza

4.80

19.82

2.4

1.3

—

Heart failure, strict

108

282

2.76

19.76

1.6

—

Nutritional anaemias

266

3.04

19.46

1.7

—

Non-ischemic cardiomyopathy

139

3.73

19.36

1.7

1.6

—

Other and unspecified dermatitis

271

3.03

19.26

1.9

1.6

—

All-cause Heart Failure

106

279

2.74

19.17

1.6

—

Other respiratory diseases principally affecting the interstitium

103

4.49

19.10

1.7

1.5

—

Streptococcal septicaemia

11.17

18.88

1.4

—

Mycoses

147

3.82

18.85

1.9

1.5

—

Endocarditis

12.03

18.72

1.4

—

Any reimbursement code in KELA

4.12

18.60

1.6

1.7

—

Iron deficiency anaemia

229

3.16

18.40

1.7

—

Asthma-related pneumonia

194

3.35

18.04

1.6

—

Bacterial pneumonia (organism specified)

230

3.06

17.94

1.5

1.6

—

Persons encountering health services in other circumstances, wide

166

388

2.22

17.77

1.6

—

Dermatitis

345

2.70

17.71

1.8

1.5

—

Tuberculosis of other organs, strict

14.78

17.65

2.3

1.3

—

Hodgkin lymphoma

14.75

17.64

1.6

1.4

—

Asthma, hospital admissions 3, pneumonia

197

3.30

17.62

1.6

—

Asthma-related pneumonia or sepsis

197

3.30

17.62

1.6

—

Failure and rejection of transplanted organs and tissues

30.15

17.58

2.8

1.3

—

Abnormal findings on examination of blood, without diagnosis

296

2.79

17.55

1.8

1.5

—

Drug-induced neutropenia

6.57

17.47

1.3

1.4

—

Glomerular diseases

107

4.22

17.34

1.7

1.6

—

Other and unspecified disorders of white blood cells

9.25

17.34

1.6

1.3

—

Rheumatoid arthritis

157

3.48

17.24

1.7

—

Other acute lower respiratory infections

295

2.79

17.23

1.7

1.6

—

Other infectious diseases

6.41

17.10

2.1

1.4

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

+∞

17.08

2.2

0.0

—

Bacterial pneumoniae

149

3.51

17.05

1.5

1.4

—

Interstitial lung disease endpoints

4.57

17.01

1.6

1.4

—

Other interstitial pulmonary diseases

4.57

17.01

1.6

1.4

—

Interstitial lung disease

4.57

17.01

1.6

1.4

—

Finngen Rheumatological endpoints

129

306

2.41

16.94

1.7

1.6

—

Viral pneumonia

5.66

16.77

1.6

1.3

—

Seropositive rheumatoid arthritis

123

3.90

16.68

1.7

—

Haemophagocytic lymphohistiocytosis

+∞

16.65

2.3

0.0

—

Conduction disorders

110

3.86

16.56

1.4

1.6

—

Tramadol

109

278

2.52

16.36

1.5

1.6

—

ILD, hospital admissions

4.46

16.09

1.7

1.4

—

Undetermined asthma, excluding more controls

8.71

15.87

1.4

1.3

—

Bronchitis

141

422

2.19

15.66

1.6

1.5

—

Thoracic aortic aneurysm

4.36

15.65

1.3

1.8

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

4.81

15.55

1.9

1.2

—

Cerebrovascular diseases (FINNGEN)

3.81

15.51

1.7

1.6

—

Other diseases of intestines

138

362

2.22

15.27

1.6

—

Presence of other functional implants

225

2.71

15.26

1.5

1.6

—

Dermatitis and eczema

144

440

2.15

15.21

1.8

1.5

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

5.61

15.01

1.4

—

Acute bronchitis

219

2.96

14.89

1.7

1.6

—

145

354

2.16

14.77

1.7

1.5

—

Gout

156

3.28

14.74

1.5

1.6

—

Hodgkin lymphoma, hilmo

10.81

14.67

1.6

—

Non-Hodgkin lymphoma, all

7.33

14.42

2.0

1.4

—

Other systemic involvement of connective tissue (FG)

118

3.71

14.28

1.5

1.7

—

Methotrexate

5.53

14.28

1.6

1.4

—

Rheumatoid arthritis, including avohilmo

220

2.92

14.15

1.6

—

Abnormalities of breathing

115

298

2.30

13.90

1.7

1.5

—

Secondary hypertension

7.88

13.85

1.8

2.0

—

Opioids

122

283

2.27

13.83

1.7

1.6

—

Gout, FINNGEN

182

3.09

13.67

1.5

—

Undetermined asthma

7.16

13.52

1.4

1.2

—

Other disorders of skin and subcutaneous tissue

377

2.34

13.39

1.8

1.5

—

Explicit bacterial Sepsis

5.58

13.34

1.4

1.5

—

ILD, hospital admissions 1, main diag only

4.36

13.31

1.6

1.3

—

Diseases of arteries, arterioles and capillaries

104

340

2.29

13.21

1.4

1.6

—

Dyspnoea

119

424

2.15

13.17

1.8

1.5

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

140

386

2.07

13.09

1.6

—

Other and unspecified iron deficiency

166

3.14

13.08

1.9

1.7

—

Medical observation and evaluation for suspected diseases and conditions

199

2.47

13.04

1.9

1.4

—

Miliary tuberculosis

+∞

12.94

1.9

0.0

—

Pleural effusion

4.25

12.88

2.1

1.4

—

Gastrointestinal diseases

120

2.93

12.81

1.7

1.4

—

Cardiovascular diseases (excluding rheumatic etc)

136

2.89

12.81

1.5

1.7

—

Dissection of aorta

8.20

12.77

1.1

1.5

—

Rare circulating lymphoid malignancy

7.61

12.72

1.7

1.3

—

Acute myeloid leukaemia

33.41

12.68

2.0

1.6

—

Provisional assignment of new diseases of uncertain etiology

229

2.76

12.61

1.7

1.5

—

Codes for special purposes

229

2.76

12.61

1.7

1.5

—

Codeine

114

283

2.22

12.50

1.6

—

Osteopathies and chondropathies

294

2.49

12.44

1.6

—

Bacterial pneumonia, not elsewhere classified

140

3.17

12.41

1.6

1.4

—

Other specified/unspecified arthritis

136

3.32

12.40

1.7

—

Glomerular disorders in diseases classified elsewhere

4.43

12.36

1.8

1.5

—

Hernia of abdominal wall, postoperative

7.74

12.28

1.1

1.3

—

Seropositive rheumatoid arthritis, wide

152

3.17

12.27

1.7

1.6

—

Cardiodefibrillation

256

2.62

12.16

1.3

1.7

—

L01XE Protein kinase inhibitors

6.05

12.13

1.6

1.5

—

Factors influencing health status and contact with health services

3.77

11.89

1.6

1.4

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

150

3.14

11.88

1.7

1.6

—

Multiple myeloma and malignant plasma cell neoplasms

7.46

11.85

1.6

1.3

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

7.46

11.85

1.6

1.3

—

Sulfasalazine

116

3.45

11.76

1.9

1.4

—

Other disorders of teeth and supporting structures

107

3.56

11.68

2.1

1.6

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

352

2.33

11.65

1.7

1.6

—

Intestinal infectious diseases

117

443

2.06

11.65

1.8

1.5

—

Other/unspecified seropositive rheumatoid arthritis

152

3.10

11.62

1.7

1.6

—

Symptoms and signs involving the circulatory and respiratory systems

124

298

2.09

11.51

1.7

1.5

—

Bronchiectasis

5.71

11.47

1.4

1.3

—

Oedema, not elsewhere classified

103

3.58

11.46

1.9

1.4

—

Other systemic involvement of connective tissue

144

3.13

11.34

1.5

1.6

—

Pain, not elsewhere classified

3.91

11.25

2.1

1.5

—

Other arthritis (FG)

150

3.07

11.23

1.8

1.7

—

Osteoporosis

133

3.16

11.14

1.4

1.5

—

Hypothyroidism (congenital or acquired)

5.36

11.12

2.6

1.8

—

Infections of the skin and subcutaneous tissue

352

2.29

11.11

2.0

1.6

—

Other arrhythmias

227

2.46

11.09

1.7

1.6

—

Headache

173

2.76

11.02

1.2

1.5

—

L04AC Interleukin inhibitors

7.95

11.02

1.2

1.8

—

Heart failure and bmi 25plus

160

2.68

10.80

1.6

—

Tuberculosis of other organs

18.11

10.76

2.3

1.3

—

Aortic aneurysm

152

2.98

10.63

1.6

1.7

—

Acute upper respiratory infections of multiple and unspecified sites

314

2.17

10.39

1.6

—

Cardiovascular diseases

115

2.80

10.39

1.5

1.8

—

Persons with potential health hazards related to communicable diseases

161

2.90

10.39

1.8

1.6

—

Covid-19 confirmed case

152

2.97

10.37

1.9

1.5

—

Diverticular disease of intestine

306

2.13

10.35

1.6

—

Candidiasis

4.17

10.33

2.1

1.5

—

Pacemaker

196

2.68

10.29

1.3

1.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

117

2.88

10.28

1.7

1.6

—

Asthma, hospital admission 2, infections

335

2.26

10.25

1.5

1.6

—

Asthma-related infections

335

2.26

10.25

1.5

1.6

—

Symptoms and signs involving the urinary system

103

391

2.04

10.06

1.6

—

In situ neoplasms

122

3.13

10.01

1.6

—

Acute sinusitis

245

2.44

9.97

1.9

1.6

—

Metabolic disorders

120

382

1.95

9.94

1.7

1.5

—

Viral infections characterized by skin and mucous membrane lesions

247

2.47

9.92

1.6

—

Benign neoplasm of colon, rectum, anus and anal canal

175

2.53

9.85

1.4

1.5

—

Diagnoses used for exclusion with ILD

157

2.87

9.81

1.7

1.6

—

4.38

9.78

2.2

1.4

—

Other disorders involving the immune mechanism, not elsewhere classified

8.21

9.75

2.0

1.5

—

Immunodeficiencies

6.87

9.74

1.7

1.5

—

Bleeding

111

411

1.97

9.72

1.6

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

7.43

9.71

2.4

1.3

—

COPD (mode)

3.43

9.64

1.7

1.3

—

Parasetamol

219

2.17

9.62

1.6

1.5

—

Hypothyroidism and >3 levothyroxin purchases

4.96

9.59

2.0

1.8

—

Hypothyroidism, levothyroxine purchases

4.96

9.59

2.0

1.8

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3.73

9.58

1.6

1.3

—

Viral pneumonia (known virus, not influenza)

10.12

9.56

1.2

1.4

—

Chronic periodontitis, complicated

4.12

9.43

1.9

1.6

—

8.68

9.36

2.1

1.4

—

Giant cell arteritis

6.58

9.36

1.3

1.5

—

Unspecified haematuria

241

2.35

9.35

1.5

1.6

—

Syncope and collapse

141

2.83

9.33

1.5

1.4

—

Adjustment and management of implanted device

3.41

9.29

1.3

1.7

—

Examination and observation for other reasons

199

2.29

9.28

1.9

1.4

—

Other diseases of urinary system

124

369

1.89

9.19

1.6

—

Gout, idiopatic and unspecified

152

2.84

9.18

1.5

1.7

—

L01XX Other antineoplastic agents

4.80

9.06

1.7

1.3

—

Type 2 diabetes, wide definition

105

348

1.97

9.04

1.6

—

Acquired haemolytic anaemia

9.28

8.99

1.5

—

Human immunodeficiency virus [HIV] disease

18.88

8.96

4.0

1.4

—

General examination and investigation of persons without complaint and reported diagnosis

199

2.20

8.87

1.6

1.4

—

Other viral diseases, not elsewhere classified

3.37

8.83

1.3

1.5

—

Venous thromboembolism

346

2.14

8.81

1.7

1.6

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

168

2.44

8.79

1.7

1.5

—

Other (seronegative) rheumatoid arthritis, wide

113

3.11

8.77

1.6

1.5

—

Multiple myeloma and malignant plasma cell neoplasms

5.36

8.69

1.6

1.3

—

Other reaction to severe stress, and adjustment disorders

163

2.70

8.63

2.0

1.4

—

Persons encountering health services in other circumstances

187

2.57

8.51

1.5

—

Sarcoidosis

3.51

8.50

1.8

1.5

—

Systemic lupus erythematosus

8.52

8.47

1.8

1.6

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

+∞

8.46

5.1

0.0

—

Other disorders of urethra and urinary system

286

2.10

8.46

1.6

—

Direct fill therapy

3.67

8.43

1.8

1.6

—

Pericarditis

7.56

8.42

1.3

1.4

—

Disorders of other endocrine glands

233

2.37

8.34

1.8

1.5

—

Other disorders of fluid, electrolyte and acid-base balance

177

2.57

8.26

1.9

1.6

—

Pain in throat and chest

294

1.98

8.20

1.7

1.5

—

Genitourinary diseases

173

2.20

8.19

1.6

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

6.13

8.18

1.8

1.3

—

Benign neoplasms

180

2.23

8.17

1.7

1.4

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

22.48

8.05

2.6

1.6

—

Mature T/NK-cell lymphomas, hilmo

22.48

8.05

2.6

1.4

—

Iron deficiency anaemia secondary to blood loss (chronic)

3.31

8.05

1.3

1.7

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

22.34

8.03

4.5

1.4

—

Kidney transplant status

5.59

8.02

2.4

1.8

—

Diseases of oral cavity, salivary glands and jaws

104

277

1.93

8.01

1.7

1.5

—

Symptoms and signs involving the skin and subcutaneous tissue

404

2.00

7.95

1.8

1.5

—

Early onset COPD, excluding more controls

3.84

7.94

1.8

1.3

—

Paroxysmal tachycardia

3.26

7.81

1.7

1.6

—

Acute upper respiratory infections

119

415

1.80

7.80

1.8

1.5

—

Pulmonary heart disease, diseases of pulmonary circulation

184

2.50

7.77

1.7

1.6

—

Disorders of lens

302

1.94

7.75

1.6

—

Follicular lymphoma

6.24

7.72

1.3

—

Diseases of the eye and adnexa

239

1.97

7.68

1.5

1.7

—

Biological medication for rheuma

3.53

7.68

1.3

1.7

—

Disorders of gallbladder, biliary tract and pancreas

118

426

1.79

7.63

1.7

1.6

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

7.40

7.56

2.2

1.5

—

Non-allergic asthma (mode), excluding more controls

4.28

7.56

1.3

1.4

—

Pulmonary embolism

169

2.55

7.55

1.8

1.5

—

Polymyalgia rheumatica

3.39

7.51

1.2

1.4

—

Gingivitis and periodontal diseases

101

275

1.90

7.48

1.7

1.5

—

Osteoporosis with pathological fracture (FG)

5.93

7.38

1.7

1.4

—

Pulmonary heart disease

171

2.52

7.38

1.8

1.5

—

Noninfective enteritis and colitis

270

2.19

7.36

1.9

1.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

366

1.96

7.31

1.9

1.6

—

Later onset COPD, excluding more controls

3.55

7.24

1.6

1.4

—

Haemorrhage from respiratory passages

187

2.39

7.24

1.7

1.5

—

Other disorders of ear

111

415

1.78

7.22

1.5

1.6

—

5-aminosalicylic acid

3.30

7.22

1.9

1.4

—

Hydronephrosis

3.93

7.15

2.0

1.3

—

SLE, strict definition

7.74

7.12

1.9

1.6

—

SLE, ICD10

7.74

7.12

1.9

1.6

—

Cough

208

2.31

7.07

1.4

1.6

—

Chronic lower respiratory diseases

135

431

1.70

7.06

1.6

—

Polyneuropathies and other disorders of the peripheral nervous system

140

2.65

7.03

2.1

1.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

153

2.33

7.00

1.6

—

Depression medications

4.03

6.99

1.5

1.7

—

Spondyloarthritis

3.08

6.99

1.6

1.5

—

Exclusions for E4_PCOS_BROAD

3.15

6.96

2.0

1.6

—

Symptoms and signs concerning food and fluid intake

5.19

6.95

1.1

1.3

—

Other and unspecified disorders of skin and subcutaneous tissue

4.86

6.93

1.7

1.3

—

Haemolytic anaemias

6.05

6.91

2.0

1.4

—

Sequelae of external causes of morbidity and mortality

153

2.55

6.91

1.7

1.6

—

Myeloproliferative diseases

3.70

6.91

1.8

1.3

—

Vocal cord dysfunction

4.65

6.89

1.3

1.7

—

Other diseases of the respiratory system

119

2.78

6.88

1.8

1.6

—

Other respiratory disorders and diseases

119

2.78

6.88

1.8

1.6

—

Iridocyclitis

125

2.73

6.84

1.9

1.5

—

Insulin medication

346

1.93

6.82

1.7

1.6

—

Unspecified acute lower respiratory infection

3.26

6.81

1.5

1.6

—

Presence of cardiac and vascular implants and grafts

207

2.16

6.81

1.4

1.5

—

Conductive and sensorineural hearing loss

100

385

1.80

6.79

1.5

1.6

—

Polyarteritis nodosa and related conditions

16.96

6.77

1.4

1.3

—

Diseases of oesophagus, stomach and duodenum

120

425

1.72

6.75

1.9

1.5

—

Invasive ventilation

4.27

6.75

1.7

1.4

—

Zoster [herpes zoster]

104

2.89

6.72

1.7

1.5

—

Unspecified kidney failure

3.72

6.63

1.5

1.3

—

Adrenocortical insufficiency

5.76

6.59

2.3

1.4

—

Immunodeficiency with predominantly antibody defects

12.35

6.59

1.9

1.3

—

SLE (Finngen)

12.31

6.58

1.8

1.4

—

Other and unspecified polyneuropathies, also in other diseases

122

2.71

6.58

2.3

1.6

—

Senile cataract

266

1.91

6.57

1.5

1.6

—

Other soft tissue disorders, not elsewhere classified

106

372

1.76

6.56

1.5

1.6

—

Symptoms and signs involving the digestive system and abdomen

119

347

1.72

6.47

1.6

1.5

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.86

6.46

2.4

1.4

—

Dermatitis due to substances taken internally

6.14

6.43

3.0

1.7

—

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

6.14

6.42

1.3

—

Pain in limb

369

1.80

6.38

1.4

1.6

—

Acute and subacute iridocyclitis

102

2.85

6.35

2.0

1.6

—

Acute lymphadenitis

5.48

6.29

2.3

1.5

—

Suppurative and necrotic conditions of lower respiratory tract

4.24

6.29

1.4

—

Other functional intestinal disorders

230

2.16

6.28

1.2

1.7

—

Exposure to unspecified factor

106

480

1.71

6.27

1.4

1.6

—

All influenza (not pneumonia)

3.45

6.27

2.7

1.3

—

Codeine or tramadol medication

128

428

1.66

6.25

1.6

—

Cellulitis

121

2.65

6.13

2.2

1.6

—

Gout, unspecified

127

2.60

6.11

1.3

1.7

—

Temporal arteritis

5.83

6.11

1.4

1.5

—

Non-allergic asthma (mode)

3.62

6.09

1.3

1.4

—

Non-invasive ventilation

2.83

6.00

1.5

1.4

—

Hypertensive diseases (excluding secondary)

122

2.29

5.99

1.4

1.6

—

Viral pneumonia (unknown virus, not influenza)

4.53

5.98

2.1

1.5

—

Other skin changes

100

2.81

5.98

1.8

1.5

—

Diseases of the ear and mastoid process

128

394

1.64

5.97

1.7

1.6

—

Glucagon-like peptide-1 (GLP-1) analogues

325

1.88

5.96

1.6

—

Insulin, combination of fast acting with intermediate-acting or long-acting

393

1.83

5.96

1.7

1.5

—

Drug-induced osteoporosis with pathological fracture

15.23

5.92

1.2

1.3

—

Inflammatory bowel disease

178

2.31

5.89

1.8

1.5

—

Abdominal and pelvic pain

116

347

1.68

5.87

1.6

1.5

—

Stomatitis and related lesions

4.18

5.82

1.9

1.7

—

Diseases of liver

211

2.18

5.81

1.8

1.6

—

Other disorders of adrenal gland

5.03

5.74

2.3

1.5

—

Lichen simplex chronicus and prurigo

4.66

5.73

1.6

—

Other special examinations and investigations of persons without complaint or reported diagnosis

199

1.91

5.73

1.7

1.4

—

Glomerulonephritis

3.34

5.71

1.9

1.6

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

2.83

5.65

1.2

1.6

—

Anterior Iridocyclitis

109

2.67

5.64

2.0

1.6

—

Myelodysplastic syndrome

13.20

5.61

2.4

1.4

—

Hypertension, essential

274

1.79

5.60

1.4

1.7

—

Respiratory tuberculosis, clinically confirmed

13.06

5.60

2.0

1.1

—

Cutaneous abscess, furuncle and carbuncle

133

2.49

5.59

2.2

1.6

—

Seronegative rheumatoid arthritis

3.29

5.57

1.7

1.6

—

Disorders of thyroid, IBD co-morbidities

3.88

5.47

1.4

1.3

—

Missing teeth due to accident, extraction or parodontitis

3.34

5.43

2.4

1.6

—

Seropositive rheumatoid arthritis, strict definition

2.96

5.40

2.0

1.6

—

Low back pain

342

1.78

5.38

1.7

1.6

—

236

2.06

5.38

1.6

—

Other/unspecified rheumatoid arthritis

3.02

5.36

1.6

1.5

—

Inflammatory bowel disease, strict (require KELA)

118

2.55

5.35

1.8

1.5

—

IBD patients in KELA-register

118

2.55

5.35

1.8

1.5

—

DVT of lower extremities and pulmonary embolism

265

2.00

5.34

1.7

1.5

—

Persons encountering health services for examination and investigation

199

1.87

5.31

1.6

1.4

—

Infection of intervertebral disc (pyogenic)

11.45

5.31

1.7

1.3

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

151

2.14

5.30

1.6

1.5

—

Sensorineural hearing loss

379

1.70

5.26

1.5

1.6

—

Insulin, fast-acting

220

2.09

5.26

1.6

—

Fluid overload

+∞

5.25

1.2

0.0

—

Neurological diseases

271

1.73

5.25

1.5

1.6

—

Spondylopathies

323

1.71

5.19

1.6

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

2.47

5.19

1.4

1.6

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

2.47

5.19

1.4

1.6

—

Other pleural conditions

3.34

5.16

2.2

1.3

—

Abnormal findings on diagnostic imaging of other body structures

3.34

5.15

1.5

—

Gout, strict definition

115

2.53

5.11

1.4

1.6

—

Follicular lymphoma, hilmo

4.22

5.09

1.3

1.5

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

150

2.12

5.05

1.5

—

Neurological diseases, wide definition

2.89

5.04

1.7

1.5

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

10.15

5.04

2.3

1.4

—

Asthma (diagnoses ohter than nonallergic)

467

1.67

5.04

1.5

1.6

—

Sleep disorders (combined)

107

434

1.62

5.02

1.5

1.6

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

107

433

1.61

4.93

1.7

1.6

—

Benign neoplasm: Colon

165

2.09

4.92

1.5

1.4

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

124

2.42

4.86

1.1

1.5

—

Convulsions, not elsewhere classified

2.92

4.86

1.4

—

External causes of morbidity and mortality

195

1.83

4.81

1.5

—

Hard cardiovascular diseases

370

1.65

4.81

1.7

1.6

—

Diabetes mellitus

105

389

1.61

4.79

1.7

1.6

—

Giant cell arteritis with polymyalgia rheumatica

4.62

4.78

1.4

—

Recurring oral aphthae

4.61

4.78

2.1

1.4

—

Other dialysis

5.04

4.78

2.4

1.5

—

Crohn disease

2.95

4.70

1.8

1.6

—

Ulcerative colitis, NAS

2.84

4.64

2.3

1.5

—

Type 2 diabetes

103

381

1.61

4.64

1.7

1.6

—

Chronic ulcer of skin, not elsewhere classified

3.70

4.64

1.5

1.2

—

Insulin, fast-acting or short human

232

1.98

4.61

1.6

—

Inflammatory diseases of the central nervous system

3.50

4.61

2.1

1.7

—

Disorders of sclera, cornea, iris and ciliary body

331

1.81

4.61

1.7

1.6

—

Ulcerative colitis

134

2.32

4.57

1.9

1.5

—

Drug-induced cataract

8.26

4.57

2.4

1.4

—

Mucosal proctocolitis

2.98

4.55

1.9

1.5

—

Ulcer of lower limb, not elsewhere classified

2.81

4.54

1.9

1.5

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

153

2.09

4.53

1.4

1.6

—

Other disorders of kidney and ureter

2.72

4.50

2.0

1.4

—

Deposits [accretions] on teeth

3.82

4.46

1.6

1.5

—

Constipation

419

1.61

4.43

1.4

1.6

—

Cholelithiasis, broad definition with cholecystitis

390

1.62

4.41

1.9

1.5

—

Gonarthrosis [arthrosis of knee](FG)

266

1.70

4.37

1.5

1.6

—

Diabetes, varying definitions

103

390

1.58

4.36

1.7

1.6

—

Viral infections of the central nervous system

3.73

4.36

2.2

1.6

—

Dental operations

212

1.74

4.28

1.7

1.6

—

Endocrine, nutritional and metabolic diseases

245

1.68

4.25

1.5

—

Arthropathies

288

1.63

4.25

1.8

1.6

—

Spondylosis

302

1.76

4.25

1.6

—

Hypertensive diseases

279

1.66

4.24

1.3

1.7

—

Hypertension

279

1.66

4.23

1.3

1.7

—

Other cataract

205

1.89

4.20

1.8

1.7

—

Sequelae with surgical and medical care as external cause

121

2.32

4.16

1.4

1.6

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

4.08

4.16

1.7

1.5

—

Melanocytic naevi

2.53

4.12

1.4

1.8

—

Hypothyroidism, drug reimbursement

4.09

4.11

1.5

2.0

—

254

1.85

4.11

1.8

1.5

—

Chronic nephritic syndrome

4.37

4.09

1.8

1.5

—

Crohn's disease NAS

3.76

4.08

1.7

—

Abnormalities of heart beat

166

2.09

4.07

1.9

1.6

—

Carrier of infectious disease

8.06

4.06

1.9

1.4

—

Disorders of mineral metabolism

3.20

4.05

1.5

1.4

—

Malignant immunoproliferative diseases

10.19

4.03

2.4

1.4

—

Respiratory disorders in diseases classified elsewhere

10.13

4.02

2.0

1.4

—

Injury, poisoning and certain other consequences of external causes

163

1.82

4.00

1.7

1.5

—

Chronic periodontitis, including avohilmo

452

1.56

3.98

1.9

1.5

—

In situ neoplasms

204

1.96

3.94

1.6

1.5

—

Other diseases of arteries and capillaries

3.13

3.92

1.1

1.4

—

Parodontitis

452

1.55

3.92

1.9

1.5

—

Benign neoplasm of mouth and pharynx

3.64

3.92

1.3

1.7

—

Parodontitis or operation codes

452

1.55

3.90

1.9

1.5

—

Herpesviral [herpes simplex] infections

2.89

3.89

1.7

1.6

—

Contact with and exposure to communicable diseases

118

2.28

3.89

1.3

1.5

—

Use of hypnotics and sedatives

112

430

1.51

3.89

1.5

1.6

—

Infectious mononucleosis

4.17

3.88

1.9

1.8

—

Discitis, unspecified

7.36

3.87

1.5

1.4

—

STROKE

270

1.70

3.86

1.6

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

150

2.04

3.85

1.8

1.5

—

Chronic sinusitis

248

1.86

3.85

1.8

1.7

—

Antihypertensive medication - note that there are other indications

146

1.87

3.83

1.6

1.7

—

Phlebitis and thrombophlebitis (not including DVT)

126

2.23

3.82

1.6

1.5

—

Asthma and opportunity respiratory infection

3.81

3.80

2.3

1.3

—

Follow-up examination after treatment for malignant neoplasms

3.07

3.80

1.3

—

Other benign neoplasms of skin

143

2.13

3.79

1.6

—

Chronic rhinitis, nasopharyngitis and pharyngitis

166

2.05

3.79

1.4

1.6

—

Episodal and paroxysmal disorders

113

386

1.50

3.77

1.5

1.7

—

Urticaria and erythema

194

1.96

3.75

1.6

—

Dorsopathies

105

352

1.52

3.74

1.8

1.6

—

Other diseases of hard tissues of teeth

261

1.71

3.71

1.6

—

Hypo-osmolality and hyponatraemia

2.39

3.69

2.3

1.6

—

Parodontitis and operation codes

454

1.54

3.68

1.9

1.5

—

Generalized skin eruption due to drugs and medicaments

5.65

3.66

2.7

1.4

—

Chronic tubulo-interstitial nephritis

5.65

3.66

2.1

1.3

—

Gastroduodenal ulcer

168

2.02

3.65

1.4

1.6

—

Disorders of optic nerve and visual pathways

3.12

3.64

1.1

1.8

—

Misadventures to patients during surgical and medical care

2.61

3.63

2.9

1.5

—

Melanocytic naevi of trunk

3.43

3.61

1.3

1.7

—

Diabetic nephropathy, excluding more controls

2.51

3.58

1.6

—

Other metabolic disorders

2.75

3.58

1.4

1.5

—

Myeloproliferative diseases (CML excluded)

2.95

3.57

1.9

1.4

—

Vasculitis limited to skin, not elsewhere classified

7.83

3.56

1.3

—

Cerebrovascular diseases

398

1.55

3.56

1.6

—

Asthma, hospital admissions , main diagnosis only

460

1.56

3.52

1.5

1.6

—

Ulcerative enterocolitis

5.32

3.51

2.3

1.4

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

5.31

3.51

1.9

1.3

—

Secondary thrombocytopenia

10.12

3.50

1.8

1.5

—

Other and unspecified immunodeficiencies with predominantly antibody defects

10.11

3.50

1.2

1.3

—

Carcinoma in situ of skin of trunk

6.19

3.50

2.3

1.2

—

Other renal tubulo-interstitial diseases

10.05

3.50

2.0

1.5

—

Benign neoplasms

100

371

1.51

3.48

1.7

1.5

—

Cardiomyopathy, other and unspecified

3.56

3.48

1.4

1.5

—

Abnormal results of function studies

3.56

3.48

1.4

1.6

—

Sleep apnoea

427

1.51

3.48

1.5

1.6

—

Hyperkalaemia

3.35

3.48

1.5

1.4

—

Other and unspecified psoriasis

3.34

3.47

1.3

1.4

—

Adalimumab

3.34

3.47

1.4

2.0

—

Skin changes due to chronic exposure to nonionizing radiation

236

1.81

3.46

1.8

1.5

—

Other antidepressants

113

402

1.47

3.43

1.5

1.6

—

Cystitis

302

1.58

3.42

1.4

1.6

—

Type 2 diabetes, definitions combined, including avohilmo

377

1.51

3.41

1.7

1.6

—

Diseases of the digestive system

295

1.73

3.41

1.5

1.6

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

2.98

3.40

1.5

1.3

—

Diseases of the musculoskeletal system and connective tissue

139

1.81

3.39

1.8

1.6

—

Diseases of pulp and periapical tissues, including avohilmo

107

376

1.48

3.38

1.6

1.5

—

Dorsalgia

349

1.51

3.37

1.7

1.6

—

Benign neoplasm: Rectum, anus and anal canal

2.50

3.37

1.4

1.6

—

Pruritus

3.10

3.36

1.2

1.5

—

Other CVD (FINNGEN)

3.07

3.36

1.2

1.4

—

Type 2 diabetes, definitions combined

372

1.51

3.36

1.7

1.6

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

335

1.67

3.36

1.4

1.6

—

Crohn disease (strict definition, require KELA, min 2 HDR)

3.71

3.35

1.6

1.9

—

Crohn disease (strict definition, require KELA)

3.71

3.35

1.6

1.9

—

Other disorders of optic [2nd] nerve and visual pathways

3.45

3.33

1.2

1.6

—

Other Crohn's disease

3.45

3.33

1.4

1.9

—

Tumor necrosis factor alpha inhibitors

2.72

3.31

1.4

1.8

—

COPD, hospital admission 2, with asthma infections

184

1.86

3.31

1.8

1.6

—

Dental pulpitis 1

107

378

1.47

3.30

1.6

1.5

—

Dental pulpitis 4

107

378

1.47

3.30

1.6

1.5

—

Hyperlipidaemia, other/unspecified

261

1.74

3.30

1.4

1.5

—

Idiopathic gout

2.62

3.30

1.6

1.4

—

Fracture of lumbar spine and pelvis

121

2.15

3.30

1.5

—

Other inflammation of eyelid

2.47

3.29

2.1

1.6

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

8.71

3.27

1.7

1.3

—

Drug-induced adrenocortical insufficiency

8.64

3.27

1.8

1.1

—

Ulcerative rectosigmoiditis

3.03

3.25

2.2

1.7

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

3.03

3.25

1.5

1.6

—

Carcinoma in situ of other and unspecified sites

4.76

3.24

1.3

1.4

—

Acute generalized exanthematous pustulosis

4.76

3.24

2.7

1.4

—

Diabetes medication

403

1.48

3.21

1.7

1.6

—

Other joint disorders

287

1.54

3.21

1.4

1.6

—

Benign neoplasm: Rectum

2.58

3.20

1.4

1.7

—

Recurring oral aphthae, including avohilmo

2.50

3.20

1.8

1.5

—

Disorders of oesophagus in diseases classified elsewhere

5.38

3.20

1.9

1.4

—

Respiratory tuberculosis, not confirmed

3.59

3.20

1.9

1.4

—

Idiopathic thrombocytopenic purpura

5.36

3.19

1.8

1.3

—

Pneumothorax

3.34

3.19

1.5

1.3

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

3.34

3.19

1.5

1.9

—

Viral meningitis

6.39

3.18

2.1

1.3

—

Psoriasis

164

1.95

3.17

1.9

1.6

—

Concussion

228

1.75

3.16

1.3

1.6

—

Sleep apnoea, including avohilmo

433

1.47

3.16

1.5

1.6

—

Care involving use of rehabilitation procedures

316

1.65

3.15

1.9

1.6

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

2.96

3.13

1.5

1.4

—

Cardiomyopathy

2.41

3.13

1.3

1.7

—

Pneumonia due to Streptococcus pneumoniae

4.52

3.11

1.8

1.4

—

Lower back pain or/and sciatica

100

477

1.45

3.11

1.7

1.6

—

COPD

249

1.69

3.10

1.7

1.6

—

Other disorders of lacrimal gland

201

1.84

3.10

1.9

1.6

—

Malignant neoplasm of bladder

2.81

3.08

1.4

1.3

—

Localized swelling, mass and lump of skin and subcutaneous tissue

180

1.89

3.08

1.8

1.6

—

Type 2 diabetes, strict (exclude DM1)

380

1.48

3.08

1.7

1.6

—

Atopic dermatitis, strict definition with reimbursement

108

2.16

3.07

1.2

1.5

—

Other and unspecified vasculitis limited to skin

7.54

3.06

1.3

1.4

—

Acute bronchiolitis

5.15

3.06

1.6

1.2

—

Other inflammatory liver diseases

3.24

3.05

1.6

1.4

—

Encephalitis

5.03

3.05

2.4

1.4

—

Abscess of lung

5.89

3.03

1.3

—

Systemic lupus erythematosus, unspecified

5.86

3.02

2.0

1.6

—

Dental pulpitis 2

243

1.56

3.01

1.7

1.6

—

Actinic keratosis

234

1.75

3.01

1.9

1.5

—

Other dorsopathies, not elsewhere classified

349

1.47

3.00

1.7

1.6

—

Cholecystitis

2.30

3.00

1.9

1.5

—

Other or ill-defined heart diseases

4.30

2.99

1.1

1.8

—

Other and unspecified acquired haemolytic anaemias

10.13

2.99

1.8

1.6

—

Atherosclerosis, excluding cerebral and coronary sclerosis

232

1.69

2.98

1.3

1.7

—

Aortic valve malfunction, age under 60 years

2.64

2.96

1.1

1.9

—

Nerve, nerve root and plexus disorders

105

462

1.43

2.94

1.4

1.6

—

Sequelae of other external causes

3.34

2.90

2.0

1.5

—

Other diseases of lip and oral mucosa

2.32

2.90

2.1

1.5

—

Persons encountering health services for specific procedures, not carried out

3.34

2.90

1.2

1.7

—

Follow-up examination after treatment for conditions other than malignant neoplasms

141

1.81

2.90

1.6

1.5

—

Psoriasis vulgaris

108

2.13

2.89

2.1

1.6

—

Chronic myeloproliferative disease

6.74

2.87

2.3

1.4

—

Sequelae of tuberculosis

5.42

2.87

2.4

1.2

—

Unspecified nephritic syndrome

5.42

2.87

2.4

1.5

—

Diseases of spleen

6.72

2.87

2.7

1.2

—

Disorders of calcium metabolism

2.94

2.86

1.3

1.4

—

Injuries to the head

104

477

1.42

2.86

1.6

—

Ulcer of oesophagus

2.94

2.86

1.4

1.5

—

Other diseases of upper respiratory tract

113

418

1.41

2.85

1.5

1.6

—

Polyarthrosis

2.15

2.82

1.4

1.7

—

Cholelithiasis

383

1.48

2.82

1.8

1.6

—

Seborrhoeic dermatitis

2.77

2.81

1.5

1.6

—

Other specific joint derangements/joint disorders

280

1.56

2.80

1.5

1.6

—

Carcinoma in situ, bladder

4.47

2.80

1.1

1.3

—

Benign neoplasm: Skin of trunk

4.46

2.79

1.5

1.3

—

Intracranial trauma

232

1.64

2.79

1.3

1.6

—

Asthma, including avohilmo

113

470

1.40

2.78

1.6

—

Disorders resulting from impaired renal tubular function

3.93

2.77

1.3

1.4

—

Preparatory care for dialysis

3.24

2.77

1.4

—

Pyothorax

3.24

2.77

1.5

—

Crohn's disease of large intestine

3.92

2.77

1.6

1.8

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

2.27

2.76

2.0

1.6

—

Acquired absence of limb

8.44

2.76

1.8

1.5

—

Other abnormalities of plasma proteins

8.40

2.75

1.8

1.5

—

Postzoster neuralgia

8.40

2.75

1.8

1.5

—

Fall on same level

111

443

1.40

2.75

1.6

—

Chronic pancreatitis

2.31

2.74

1.4

1.6

—

Meniscus derangement

250

1.59

2.74

1.5

1.7

—

Disorders of choroid and retina

419

1.46

2.73

1.6

—

Anaemia in chronic diseases classified elsewhere

5.03

2.73

1.3

1.5

—

Other encephalitis

5.03

2.73

2.6

1.4

—

Abnormal findings on diagnostic imaging of central nervous system

5.02

2.73

1.4

—

Benign neoplasm: Skin of eyelid, including canthus

2.60

2.70

1.9

1.4

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

2.51

2.70

1.1

1.8

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.50

2.69

1.5

1.8

—

Other noninfective gastroenteritis and colitis

132

1.97

2.68

2.0

1.5

—

Other chronic obstructive pulmonary disease

243

1.64

2.68

1.7

—

Insulin, intermediate and long-acting

373

1.55

2.68

1.4

1.5

—

Peripheral artery disease

248

1.62

2.66

1.3

1.7

—

Other ulcerative colitis

3.13

2.64

1.7

1.6

—

Other complications of surgical and medical care, not elsewhere classified

2.80

2.64

2.3

1.5

—

Accidents

299

1.46

2.63

1.5

1.6

—

Chronic gastritis

169

1.84

2.61

1.8

1.6

—

Disorders of eyelid, lacrimal system and orbit

439

1.45

2.58

1.8

1.5

—

Dialysis

3.62

2.57

1.4

—

Nausea and vomiting

132

1.94

2.57

1.8

1.6

—

Carcinoma in situ of skin of trunk

4.02

2.57

2.3

1.3

—

Nephrotic syndrome

4.02

2.57

2.6

1.4

—

Other specified and unspecified retinal disorders

4.02

2.57

2.6

1.3

—

Lung diseases due to external agents

2.19

2.56

1.4

—

Ulcerative colitis (strict definition, require KELA)

2.19

2.56

2.0

1.6

—

Carcinoma in situ of skin, other sites/unspecified

7.22

2.55

1.8

1.4

—

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

7.21

2.55

1.4

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

380

1.43

2.55

1.7

1.6

—

Acute epiglottitis

7.19

2.55

2.8

1.4

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

7.19

2.55

1.2

1.3

—

Budesonide

2.73

2.54

2.3

1.4

—

Diseases of external ear

193

1.76

2.53

2.2

1.6

—

Anxiety disorders

392

1.45

2.51

2.0

1.6

—

Pain in joint

237

1.56

2.50

1.5

1.6

—

Diabetic nephropathy

100

2.08

2.50

1.6

1.7

—

Fracture of foot, except ankle

122

1.97

2.49

1.6

1.5

—

Other external causes of accidental injury

299

1.44

2.47

1.5

1.6

—

Unknown and unspecified causes of morbidity

3.82

2.46

1.5

1.3

—

Neurotic, stress-related and somatoform disorders

389

1.44

2.46

2.0

1.6

—

Benign neoplasm of other and ill-defined parts of digestive system

2.38

2.46

1.8

1.7

—

Weight loss

2.46

2.44

1.0

1.4

—

Other diseases of biliary tract

2.55

2.44

1.2

1.3

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

2.08

2.43

1.3

1.5

—

Arthrosis

263

1.48

2.42

1.4

1.7

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

5.02

2.40

1.2

1.4

—

Artificial opening status

3.34

2.39

1.4

—

Pain (limb, back, neck, head abdominally)

248

1.48

2.38

1.6

—

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

6.30

2.37

1.2

1.3

—

Malnutrition

6.28

2.37

1.4

—

Hyperprolactinaemia

6.27

2.37

2.2

1.8

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

2.75

2.37

1.3

—

Disorders of parathyroid gland

116

1.96

2.36

1.5

1.4

—

Calcific aortic valvular stenosis

193

1.73

2.36

1.3

1.6

—

Calcific aortic valvular stenosis, operated

193

1.73

2.36

1.3

1.6

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

4.15

2.36

1.1

1.4

—

Crohn disease (strict definition, all UC cases excluded)

3.65

2.36

1.5

—

Other and unspecified drugs and medicaments

2.61

2.35

1.6

—

Intestinal adhesions without obstruction

2.61

2.35

2.6

1.3

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

107

1.99

2.35

1.2

1.6

—

Pain in thoracic spine

2.26

2.34

2.1

1.5

—

Use of anticholinesterases

178

0.41

2.33

1.3

1.5

—

N06DA Anticholinesterases

178

0.41

2.33

1.3

1.5

—

Other diseases of the digestive system

206

1.70

2.32

1.5

1.7

—

Cirrhosis of liver, NAS

2.87

2.30

2.1

1.5

—

Presence of other devices

105

2.00

2.29

1.9

1.4

—

Infections with a predominantly sexual mode of transmission

119

1.93

2.29

1.6

—

Hypothyroidism, strict autoimmune

248

1.52

2.28

2.0

1.5

—

Gastro-oesophageal reflux disease

393

1.47

2.28

1.9

1.5

—

Erythema multiforme

4.64

2.27

1.3

—

Volume depletion

2.46

2.27

1.1

1.3

—

Benign neoplasm: Other and unspecified parts of mouth

4.63

2.27

1.5

1.3

—

Benign neoplasm: Skin of trunk

3.49

2.27

1.5

1.4

—

Papulosquamous disorders

246

1.63

2.26

1.7

1.6

—

Multiple myeloma

3.91

2.25

2.0

1.4

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

3.91

2.25

2.0

1.4

—

Exclusions for E4_PCOS_CONSORTIUM

220

1.54

2.25

1.7

1.5

—

Other and unspecified follicular disorders

3.90

2.25

2.3

1.5

—

Peripheral arterial reconstruction

106

1.98

2.25

1.6

1.5

—

Amputation

2.28

2.24

1.4

1.3

—

Other disorders of the musculoskeletal system and connective tissue

2.10

2.22

1.4

1.6

—

Ischemic heart diseases

370

1.41

2.22

1.5

1.6

—

Papilloedema, unspecified

5.58

2.21

1.0

1.2

—

Long labour

2.22

2.21

1.3

1.7

—

Disorders of refraction and accommodation

128

1.87

2.18

1.9

1.5

—

Mixed conductive and sensorineural hearing loss

2.24

2.17

1.2

1.5

—

Benign neoplasm of colon, rectum, anus and anal canal

398

1.45

2.16

1.4

1.6

—

Disorders of optic nerve, not elsewhere classified

4.31

2.15

1.3

1.4

—

Cystic kidney disease

3.70

2.15

1.3

1.4

—

Psoriasis (vulgaris), strict definition

3.70

2.15

3.7

1.8

—

Carcinoma in situ of other and unspecified sites

3.01

2.15

1.3

1.4

—

Oesophagitis

3.01

2.14

3.2

1.4

—

Crohn's disease of small intestine

3.01

2.14

1.9

1.8

—

Malignant neoplasm of skin

325

1.46

2.14

1.7

1.6

—

Diabetes, insulin treatment (Kela reimbursement)

416

1.37

2.13

1.7

1.6

—

Non-selective monoamine reuptake inhibitors

228

1.62

2.11

1.5

1.6

—

Congenital malformations, deformations and chromosomal abnormalities

316

1.52

2.11

1.3

1.7

—

Hypokalaemia

2.21

2.10

1.7

1.6

—

Cholangitis (primary sclerosing, PSC)

2.71

2.10

1.4

—

Cardiomyopathies, Primary/intrinsic

2.45

2.10

1.2

1.7

—

Dental pulpitis 2, only avohilmo

261

1.43

2.09

1.7

1.6

—

Operations 2 for CAVS

193

1.67

2.09

1.3

1.6

—

Calcific aortic valvular stenosis, diagnosis (helper)

193

1.67

2.09

1.3

1.6

—

Simple and mucopurulent chronic bronchitis

3.21

2.09

1.3

1.4

—

Disorders of lipoprotein metabolism and other lipidaemias

360

1.40

2.09

1.6

1.5

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

3.21

2.09

1.4

1.7

—

Calcific aortic valvular stenosis, including rheumatic fever

193

1.67

2.09

1.3

1.6

—

COPD, hospital admissions

279

1.52

2.08

1.7

1.6

—

Adult respiratory distress syndrome

5.04

2.07

2.4

1.4

—

Other diseases of jaws

2.91

2.07

2.8

1.7

—

Hernia

442

1.37

2.07

1.5

1.6

—

GI-bleeding

206

1.65

2.06

1.6

1.7

—

Other intervertebral disc disorders

336

1.40

2.06

1.5

1.6

—

Psychiatric diseases

107

401

1.34

2.05

1.8

1.5

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

464

1.36

2.04

1.5

1.6

—

Reactive arthropathies

2.40

2.02

1.3

1.7

—

Fentanyl

2.40

2.02

1.4

—

Peripheral artery operations in Hilmo

2.11

2.01

1.3

1.5

—

Allergic asthma (mode), excluding more controls

2.51

2.01

1.6

1.3

—

Paralytic ileus and intestinal obstruction

147

1.77

2.01

2.0

1.7

—

Problems related to lifestyle

2.50

2.01

1.5

—

Dental caries, including avohilmo

285

1.40

1.99

1.6

—

Dental caries 1

285

1.40

1.99

1.6

—

Dental caries 3

298

1.39

1.99

1.6

—

Continuous positive airway pressure

1.98

1.99

1.5

1.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

253

1.57

1.99

1.8

1.6

—

Injuries to the hip and thigh

262

1.54

1.98

1.5

1.6

—

Parodontitis or/and operation codes

264

1.44

1.98

1.9

1.5

—

Other embolism and thrombosis

2.15

1.98

1.9

1.6

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

215

1.62

1.97

1.5

1.6

—

Disorders of lacrimal system

248

1.57

1.97

1.9

1.6

—

Basal cell carcinoma

305

1.46

1.97

1.6

—

Postmenopausal atrophic vaginitis

0.34

1.96

3.2

1.5

—

Respiratory insufficiency

3.33

1.96

1.9

1.1

—

Soft tissue disorders

375

1.34

1.95

1.6

—

Dental caries 3 and operation codes

322

1.37

1.95

1.8

1.6

—

COPD, early/later onset

283

1.49

1.95

1.7

1.6

—

Any mental disorder

108

409

1.32

1.94

1.8

1.5

—

Respiratory conditions due to other external agents

4.57

1.94

1.4

1.5

—

Other headache syndromes

202

1.63

1.94

1.2

1.7

—

Other and unspecified diseases of blood and blood-forming organs

3.77

1.93

1.3

—

Polycythaemia vera

3.76

1.93

2.0

1.4

—

Hypoparathyroidism

3.76

1.93

1.5

1.4

—

Need for other prophylactic measures

2.73

1.93

1.3

1.5

—

Thyroiditis, ILD-related definition

2.45

1.93

1.4

—

Other congenital malformations

2.73

1.93

1.7

1.9

—

Artificial joint operation, meniscal resection

445

1.35

1.92

1.5

1.6

—

Dental caries 1 and operation codes

310

1.37

1.92

1.6

—

Elevated blood glucose level

2.57

1.92

1.7

1.4

—

Sicca syndrome [Sjögren]

2.57

1.92

1.7

1.6

—

Fissure and fistula of anal and rectal regions

135

1.78

1.90

1.5

1.6

—

Other or unspecified ileus, impaction or obstruction

1.92

1.89

2.3

1.7

—

Persons encountering health services in circumstances related to reproduction

244

0.56

1.87

1.2

1.6

—

Cardiomyopathy (excluding other)

2.31

1.87

1.2

1.7

—

Carcinoma in situ, bladder

2.87

1.86

1.1

1.5

—

Pediculosis, acariasis and other infestations

2.86

1.86

1.4

1.8

—

Basal cell carcinoma, including avohilmo

312

1.44

1.85

1.6

—

Stroke, excluding SAH

331

1.41

1.85

1.5

1.6

—

Other diseases of pancreas

2.40

1.85

1.3

1.5

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

100

1.90

1.85

1.9

1.6

—

Other arthrosis

236

1.49

1.84

1.4

1.7

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

2.21

1.84

1.4

1.5

—

Acute posthaemorrhagic anaemia

3.54

1.84

1.5

1.4

—

Amputation of thigh

3.54

1.84

2.0

1.4

—

Hyperfunction of pituitary gland

3.54

1.84

2.3

1.6

—

Other specified/unspecified inflammatory spondylopathies

3.54

1.84

1.7

1.4

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

294

1.45

1.83

1.6

—

Pyogenic arthritis

2.51

1.83

1.6

1.5

—

Erythema nodosum

4.18

1.82

2.4

1.3

—

Ovarian dysfunction

4.17

1.82

1.4

2.6

—

Duodenal ulcer

2.12

1.81

1.2

1.5

—

Other retinal disorders

347

1.41

1.81

1.6

—

Gonarthrosis

250

1.42

1.81

1.5

1.7

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

101

1.88

1.80

2.0

1.5

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.96

1.79

1.4

1.6

—

Varicose veins

314

1.42

1.79

1.5

1.6

—

Anxiety disorders, excluding more controls

347

1.38

1.79

2.1

1.5

—

Open wound of head

347

1.45

1.78

2.0

1.5

—

Benign neoplasm: Colon, unspecified

1.91

1.77

1.4

1.6

—

Major coronary heart disease event

367

1.36

1.77

1.6

1.5

—

Cholecystectomy

407

1.39

1.77

2.0

1.6

—

Dysphagia

131

1.76

1.77

1.6

1.7

—

Dental pulpitis 4, only avohilmo

104

416

1.31

1.76

1.6

—

Paracetamol of NSAID medication

1.89

1.76

1.3

1.6

—

Other diseases of intestine

2.09

1.75

1.9

1.6

—

Ischaemic heart disease, wide definition

371

1.35

1.75

1.5

1.6

—

Bacterial, viral and other infectious agents

2.44

1.75

2.4

1.8

—

Decubitus ulcer and pressure area

2.51

1.74

1.4

1.3

—

Thyroiditis

2.50

1.74

1.4

1.6

—

Ocular pain

2.50

1.74

1.3

1.7

—

Kela-code for severe mental illness

218

0.46

1.74

1.3

1.6

—

Barrett oesophagus

2.67

1.72

1.6

—

Presbyopia

2.67

1.72

3.0

1.9

—

Haemangioma, any site

2.67

1.72

2.5

1.6

—

Haemangioma and lymphangioma, any site

2.67

1.72

2.5

1.6

—

Orthopaedic devices associated with adverse incidents

3.87

1.72

1.0

1.5

—

Carcinoma in situ of other and unspecified digestive organs

3.86

1.71

1.0

1.3

—

Benign neoplasm: Sigmoid colon

2.06

1.70

1.1

1.7

—

Falls/tendency to fall

104

401

1.30

1.69

1.5

1.6

—

Tinnitus

133

1.73

1.69

1.4

1.7

—

Asthma/COPD (KELA code 203)

428

1.33

1.69

1.6

—

Other disorders of patella

1.95

1.69

1.3

1.7

—

Hydrocephalus

0.00

1.68

0.0

1.3

—

Disorders of vestibular function (Vertigo)

281

1.49

1.68

1.4

1.7

—

Conductive hearing loss, unspecified

2.38

1.67

1.3

—

Cardiac arrest

2.88

1.66

1.6

1.5

—

Small fibre neuropathy

3.17

1.66

2.8

1.4

—

Allergic urticaria

2.58

1.66

1.8

1.7

—

Other CVD

119

1.77

1.65

1.2

1.5

—

Fracture of rib(s), sternum and thoracic spine

188

1.60

1.65

1.3

1.6

—

Oesophageal varices

2.81

1.65

1.9

1.4

—

Malignant neoplasm of eye, brain and central nervous system

2.81

1.65

1.0

1.4

—

Other specified/unspecified systemic involvement of connective tissue

2.81

1.65

1.4

1.8

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

2.04

1.65

1.5

—

Fibrosis and cirrhosis of liver

2.25

1.63

2.2

1.6

—

Pneumonitis due to solids and liquids

2.25

1.63

1.5

1.3

—

Other retinal artery occlusion

3.59

1.61

1.2

1.4

—

Impetigo

3.58

1.61

1.8

1.4

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

166

1.63

1.60

1.6

—

Hypopituitarism

2.50

1.59

1.6

1.8

—

Congenital malformations of cardiac septa

2.71

1.58

1.3

1.6

—

Malignant neoplasm of brain

3.01

1.58

1.0

1.4

—

Disorders of orbit

3.01

1.58

1.7

1.4

—

Scabies

3.01

1.58

1.3

1.8

—

Other specified disorders of external ear

2.70

1.58

1.4

1.5

—

Exposure to other specified factors

450

1.35

1.58

1.6

—

Biomechanical lesions, not elsewhere classified

2.70

1.58

1.4

1.5

—

Congenital malformations of the urinary system

2.70

1.58

1.3

1.5

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

2.70

1.58

2.0

1.7

—

Visual disturbances and blindness

312

1.44

1.58

1.5

1.6

—

Heart failure and coronary heart disease

182

1.52

1.58

1.6

—

Abnormal weight loss

2.20

1.57

1.0

1.4

—

Stroke, including SAH

354

1.36

1.56

1.5

1.6

—

Visual disturbances

288

1.46

1.56

1.5

1.6

—

Other endocrine disorders

3.44

1.55

1.2

1.3

—

Covid-19 suspected case

1.85

1.55

1.2

1.5

—

Coronary atherosclerosis

341

1.34

1.55

1.6

1.5

—

Infective dermatitis

2.11

1.55

1.2

1.6

—

Spontaneous abortion

129

0.47

1.54

1.3

1.7

—

Spondylopathies (FG)

2.03

1.54

1.5

1.8

—

Osteonecrosis

2.43

1.53

2.4

1.4

—

Other follicular disorders

2.43

1.53

2.1

1.9

—

Maternal care for known or suspected fetal abnormality and damage

0.00

1.53

0.0

1.8

—

Other enthesopathies

184

1.58

1.53

1.2

1.7

—

Other disorders of veins

216

1.53

1.52

1.4

1.6

—

Hepatic failure, not elsewhere classified

2.60

1.51

1.6

1.4

—

Hyperparathyroidism

1.80

1.51

1.6

1.4

—

Etanercept

2.60

1.51

1.6

1.8

—

Ulcerative proctitis

2.60

1.51

2.6

1.5

—

Other (not insulin) diabetes medications

393

1.30

1.51

1.6

—

Early onset COPD

138

1.67

1.51

1.8

1.7

—

ILD-related respiratory insufficiency

2.87

1.50

1.0

1.3

—

Unspecified chronic bronchitis

2.86

1.50

1.5

1.4

—

Depression or dysthymia

292

1.34

1.49

1.7

1.6

—

Unspecified mental disorder

244

0.53

1.49

1.4

1.6

—

Other disorders of eye and adnexa

2.00

1.48

1.4

1.6

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

2.00

1.48

2.4

1.7

—

Ascites

2.44

1.48

1.3

1.4

—

Dental pulpitis 1, only avohilmo

102

419

1.27

1.47

1.5

1.6

—

Other maternal disorders predominantly related to pregnancy

162

0.54

1.46

1.2

1.6

—

COPD related to multimorbidity

238

1.45

1.46

1.7

1.6

—

Amputation of toe

2.23

1.46

1.3

1.4

—

Carcinoma in situ of skin of other and unspecified parts of face

2.37

1.45

1.4

1.3

—

Pregnancy with abortive outcome

163

1.44

1.45

1.6

—

Suggestive for eosinophilic asthma

2.12

1.44

1.4

1.6

—

Allergic asthma (mode)

2.12

1.44

1.6

1.3

—

Dronedarone medication

3.13

1.44

1.2

1.4

—

Chorioretinal inflammation

3.13

1.44

2.4

1.3

—

Noninfectious colitis NAS

1.92

1.43

2.0

1.5

—

Other disorders of gingiva or/and edentulous alveolar ridge

2.73

1.43

1.8

1.4

—

Episcleritis

2.73

1.43

2.3

2.0

—

Deviated nasal septum

236

1.48

1.43

1.3

1.7

—

Emphysema

2.31

1.43

1.8

1.3

—

Retention of urine

185

1.51

1.43

1.4

1.6

—

Allergic conjunctivitis

273

1.44

1.42

1.8

1.5

—

Acute pharyngitis

2.10

1.42

1.1

1.5

—

Congenital malformations of the circulatory system

1.86

1.41

1.3

1.7

—

Urticaria

149

1.61

1.40

1.5

1.6

—

Gastric ulcer

103

1.75

1.40

1.6

1.5

—

Sequelae of infectious and parasitic diseases

2.25

1.40

2.1

1.8

—

Coxarthrosis [arthrosis of hip](FG)

230

1.42

1.39

1.2

1.6

—

Obesity related asthma

197

1.52

1.39

1.4

1.6

—

Special screening examination for infectious and parasitic diseases

1.84

1.39

1.8

1.3

—

Scleritis and episcleritis

2.42

1.39

2.1

1.9

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

2.42

1.39

2.0

1.6

—

Atopic dermatitis

216

1.46

1.39

1.7

1.5

—

Rheumatism, unspecified

1.89

1.38

1.4

1.6

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

1.89

1.38

2.0

1.6

—

Squamous cell neoplasms and carcinomas of the skin

1.89

1.38

1.5

1.4

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

2.08

1.38

2.4

1.6

—

Melanocytic naevi of trunk

2.00

1.38

1.3

1.6

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

104

1.59

1.37

1.4

1.5

—

Type of accident

158

1.58

1.37

1.6

1.5

—

Osteomyelitis

2.20

1.37

1.3

1.4

—

therapeutic use

2.62

1.37

4.2

1.4

—

Benign neoplasm: Other and unspecified parts of mouth

2.62

1.37

1.5

—

Bicuspidal aortic valve syndrome

2.62

1.37

1.3

1.4

—

Congenital malformations of aortic and mitral valves

2.61

1.37

1.3

1.4

—

Intestinal malabsorption

2.61

1.37

1.8

1.5

—

Congenital malformations of heart and great arteries

1.94

1.36

1.3

1.6

—

Carcinoma in situ of other and unspecified digestive organs

2.95

1.36

1.0

1.4

—

IgA nephropathy (IgA glomerulonephritis)

2.95

1.36

3.4

1.5

—

Postpartum haemorrhage due to anatomy

2.94

1.36

1.6

1.4

—

Malignant neoplasm of breast

171

1.48

1.35

1.4

1.6

—

Prepatellar bursitis

0.00

1.34

0.0

1.6

—

Use of galantamine

0.00

1.34

0.0

1.2

—

Type 1 diabetes, definitions combined

0.00

1.34

0.0

1.7

—

Type 1 diabetes, strict (exclude DM2)

0.00

1.34

0.0

1.7

—

Neuromuscular dysfunction of bladder

2.13

1.33

1.4

—

Unspecified urinary incontinence

2.15

1.33

1.7

1.5

—

Inguinal hernia, bilateral

1.91

1.33

2.2

1.7

—

Other and unspecified nerve root and plexus disorders, also in other diseases

105

1.72

1.32

1.4

1.6

—

Other chronic obstructive pulmonary disease, including avohilmo

325

1.36

1.32

1.7

1.6

—

Disorders of psychological development

0.00

1.32

0.0

1.3

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

192

1.51

1.31

1.6

1.5

—

Other vitreous opacities

2.51

1.30

1.3

1.4

—

Extreme obesity with alveolar hypoventilation

2.51

1.30

1.5

—

Left ventricular outflow tract obstruction, narrow definition

2.50

1.30

1.3

1.6

—

Other symptoms and signs involving the circulatory and respiratory systems

2.50

1.30

1.0

1.3

—

Nonorganic sleeping disorders, excluding more controls

1.84

1.29

1.4

—

Polyuria

129

1.63

1.29

2.3

1.7

—

Dizziness and giddiness

410

1.31

1.29

1.4

1.6

—

Carcinoma in situ of skin

2.36

1.29

2.1

1.3

—

Other hammer toe(s) (acquired)

1.77

1.29

1.6

—

Essential (haemorrhagic) thrombocythaemia

2.78

1.28

1.6

1.3

—

Ulcerative ileocolitis

2.78

1.28

3.2

1.4

—

Varicella [chickenpox]

2.78

1.28

1.2

2.1

—

Inguinal or femoral hernia, bilateral

1.89

1.28

2.2

1.7

—

HSIL lesion of the cervix uteri

2.08

1.27

1.7

1.6

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

2.09

1.27

1.3

1.6

—

Dental operations, only avohilmo

270

1.31

1.27

1.7

—

Acute pancreatitis

122

1.64

1.27

1.6

—

Septal defects

2.45

1.27

1.3

1.4

—

Other aneurysm

2.29

1.27

1.3

1.4

—

Nonsuppurative otitis media

1.73

1.26

1.4

1.6

—

Ischaemic Stroke, excluding all haemorrhages

317

1.34

1.26

1.5

1.6

—

Glucosamine medication

267

1.38

1.25

1.5

1.6

—

Benign lipomatous neoplasm

107

1.68

1.25

2.7

1.6

—

Myocardial infarction

289

1.34

1.25

1.7

1.6

—

Superficial injury of hip and thigh

1.82

1.25

1.2

1.4

—

Secondary right heart disease

2.41

1.24

1.0

1.4

—

Other diseases of stomach and duodenum

2.23

1.24

1.5

1.3

—

Varicose veins of other sites

2.23

1.24

2.0

1.7

—

Disorders of skin appendages

261

1.42

1.23

2.0

1.6

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

113

0.52

1.23

1.3

1.6

—

Type 1 diabetes, wide definition, subgroup 1

100

1.70

1.22

1.5

—

Arthropathic psoriasis

1.91

1.22

2.7

1.8

—

Lyme disease

147

1.57

1.22

1.4

1.6

—

Otitis externa, unspecified

1.97

1.22

3.6

1.8

—

Other and unspecified acute skin changes due to ultraviolet radiation

2.64

1.21

1.8

1.3

—

Malignant neoplasm, without specification of site

2.64

1.21

1.0

1.4

—

Rheumatic fever incl heart disease

2.64

1.21

1.0

1.4

—

Arterial embolism and thrombosis of lower extremity artery

2.64

1.21

1.0

1.5

—

Acute peritonitis

2.17

1.21

1.3

1.5

—

Adverse effects, not elsewhere classified

1.72

1.21

1.4

1.6

—

Other disorders of the genitourinary system

1.83

1.19

1.5

1.4

—

Melanocytic naevi, other sites/unspecified

2.31

1.18

1.7

2.0

—

Meningitis

2.31

1.18

1.0

1.5

—

Major coronary heart disease event excluding revascularizations

353

1.29

1.18

1.7

1.5

—

Vitamin B12 deficiency anaemia

1.88

1.18

2.0

1.4

—

Fracture of femur

128

1.57

1.17

1.5

—

Injuries to the thorax

298

1.38

1.17

1.3

1.6

—

Hypotension

1.70

1.17

1.3

1.4

—

Collagenous colitis

1.93

1.17

1.7

1.3

—

Other spirochaetal diseases

149

1.54

1.16

1.4

1.6

—

Lesion of plantar nerve

0.00

1.16

0.0

1.6

—

Amputation of foot

2.51

1.15

1.6

1.5

—

Other acute skin changes due to ultraviolet radiation

2.51

1.15

1.8

1.4

—

Propionic acid derivatives

139

0.61

1.15

1.4

1.7

—

Ankylosing spondylitis, strict definition

2.50

1.15

1.6

1.8

—

Benign neoplasm: Caecum

2.05

1.15

1.4

1.5

—

Normal-pressure hydrocephalus

0.00

1.15

0.0

1.3

—

Injury of other and unspecified intrathoracic organs

0.00

1.15

0.0

1.6

—

Alzheimer disease, including avohilmo

171

0.59

1.15

1.5

—

Prolonged pregnancy

0.00

1.14

0.0

1.8

—

Other diseases of anus and rectum

166

1.51

1.14

1.6

1.7

—

Deforming dorsopathies

150

1.53

1.14

1.6

—

Diseases of inner ear

344

1.34

1.13

1.4

1.6

—

Diseases of salivary glands

1.69

1.13

1.9

1.6

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

103

1.51

1.12

1.4

1.5

—

Unspecified jaundice

2.34

1.12

3.6

1.4

—

Mental and behavioural disorders due to sedatives or hypnotics

2.34

1.12

1.4

1.8

—

Nummular dermatitis

2.00

1.12

1.4

1.5

—

Leiomyoma of uterus

1.56

1.12

1.6

—

Disorders of the thyroid gland

424

1.25

1.11

1.9

1.6

—

Viral warts

1.96

1.11

1.6

1.8

—

Benign neoplasm: Ascending colon

1.96

1.11

2.2

1.5

—

Lumbar disc prolapse

328

1.31

1.10

1.6

—

Benign neoplasm of breast

2.26

1.10

1.6

—

Hallux valgus (acquired)

126

1.49

1.10

1.5

1.7

—

Substance use, excluding alcohol

1.67

1.10

1.6

—

Atopic dermatitis, strict definition

117

1.59

1.09

1.3

1.6

—

Bacterial meningitis

2.39

1.09

1.0

1.4

—

Postprocedural disorders of digestive system, not elsewhere classified

2.39

1.09

1.2

1.4

—

Macular hole

1.96

1.09

1.4

—

Cyst of kidney

1.95

1.08

2.3

1.4

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1.82

1.08

1.3

1.7

—

Bronchitis, not specified as acute or chronic

1.95

1.08

1.6

—

Type 1 diabetes, wide definition

104

1.63

1.08

1.5

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

264

1.38

1.08

1.6

1.5

—

Abrasion of teeth

1.58

1.08

2.3

1.5

—

L02BG Aromatase inhibitors

136

1.55

1.08

1.3

1.6

—

Acute pancreatitis (for exclusion)

128

1.56

1.08

1.6

1.5

—

Myocardial infarction, without ST-elevation

264

1.36

1.06

1.5

1.6

—

Superficial injury of abdomen, lower back and pelvis

1.76

1.06

1.5

1.6

—

Haemorrhoids and perianal venous thrombosis

169

1.48

1.06

1.3

1.7

—

Idiopathic pulmonary fibrosis

1.93

1.06

2.0

1.3

—

Other enthesopathy of foot (+metatarsalgia)

1.93

1.06

1.3

1.4

—

Unspecified misadventure during surgical and medical care

2.13

1.05

5.6

1.5

—

Benign neoplasm: Cerebral meninges

2.12

1.05

1.9

1.6

—

Abdominal aortic aneurysm (AAA)

1.85

1.05

2.4

1.5

—

Benign neoplasm of mouth and pharynx

1.79

1.04

1.3

1.6

—

Foreign body on external eye

1.67

1.03

2.0

1.6

—

Alcohol-induced acute pancreatitis

2.28

1.03

1.0

1.8

—

Attention to artificial openings

2.28

1.03

1.2

1.5

—

Other epidermal thickening

2.28

1.03

2.0

1.4

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

1.96

1.03

3.2

1.4

—

Benign neoplasm of brain and other parts of central nervous system

2.28

1.03

1.0

1.7

—

Inflammatory disorders of breast

2.28

1.03

4.8

1.9

—

Perineal laceration during delivery

2.08

1.03

1.4

1.9

—

Behavioural syndromes associated with physiological disturbances and physical factors

146

1.51

1.02

1.4

1.6

—

Metatarsalgia

1.92

1.02

1.2

1.4

—

Colonic or urogenital fistula

171

1.46

1.01

1.5

1.6

—

Somatoform disorder

1.69

1.01

2.1

1.4

—

Other and unspecified tonsillitis

117

1.52

1.00

2.3

1.6

—

Melanocytic naevi

155

1.48

1.00

1.4

1.6

—

Carcinoma in situ of skin of other and unspecified parts of face

1.88

1.00

1.4

1.3

—

Mixed connective tissue disease

2.00

1.00

1.9

1.7

—

Cervical disc disorders

239

1.38

1.00

1.6

—

Other other unspecified disorders of the circulatory system

2.18

0.98

1.2

1.4

—

Polyarthritis, unspecified

2.18

0.98

1.6

1.8

—

Separation of retinal layers (serosa)

2.18

0.98

1.6

1.9

—

Total colectomy operation

2.18

0.98

1.2

1.4

—

Total colectomy

2.18

0.98

1.2

1.4

—

Ingrowing nail

2.18

0.98

2.8

1.8

—

Malignant neoplasm of breast, HER2-negative

169

1.39

0.97

1.4

1.6

—

Primary angle-closure glaucoma

0.00

0.97

0.0

1.4

—

Residual foreign body in soft tissue

0.00

0.97

0.0

1.7

—

Unspecific neurodegenerative disorder

197

0.66

0.97

1.4

1.5

—

Other gastritis (incl. Duodenitis)

140

1.50

0.97

2.7

1.6

—

Urethral stricture

1.95

0.97

2.0

1.4

—

Benign neoplasm of meninges

1.95

0.97

1.9

1.6

—

Traumatic amputation of wrist and hand

0.00

0.96

0.0

1.5

—

Injury of muscle and tendon at shoulder and upper arm level

282

0.67

0.94

1.7

1.6

—

Other disorders of nervous system

1.89

0.94

1.4

—

Other diseases of blood and blood-forming organs

1.89

0.94

1.3

—

Use of donepezil

113

0.51

0.94

1.3

1.4

—

Other and unspecified effects of external causes

133

1.50

0.94

1.5

1.6

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1.60

0.93

1.5

1.6

—

Other pulmonary heart/vessel disease

2.23

0.93

1.0

1.3

—

Viral and other specified intestinal infections

1.72

0.93

1.3

—

Personal history of other diseases and conditions

2.21

0.93

1.5

1.4

—

Other condition

1.72

0.92

2.0

1.7

—

Coxarthrosis

222

1.31

0.92

1.2

1.6

—

Other diseases of oesophagus

1.82

0.92

1.1

1.4

—

Other neurological diseases

414

1.24

0.92

1.5

1.6

—

Diabetic neuropathy

1.71

0.90

1.5

1.8

—

Nonorganic sleeping disorders

1.63

0.90

1.4

1.6

—

Hypothyroidism, other/unspecified

387

1.23

0.90

2.0

1.6

—

Correction of physiology of bite - demanding therapy visit

2.07

0.89

1.0

1.8

—

Fibromyalgia

2.07

0.89

1.2

1.3

—

Contraceptive management

163

0.65

0.89

1.3

1.7

—

FESS (DNB20)

1.69

0.88

1.2

1.7

—

Childhood allergy (age < 16)

2.06

0.88

1.2

—

Postprocedural musculoskeletal disorders, not elsewhere classified

1.91

0.88

1.5

—

Dental caries 3, only avohilmo

323

1.22

0.87

1.6

—

Lung cancer and mesothelioma

1.74

0.87

1.5

1.3

—

Appendectomy

380

1.27

0.87

2.1

1.6

—

Alcohol-induced chronic pancreatitis

1.86

0.87

1.1

1.7

—

Flat foot [pes planus] (acquired)

1.86

0.87

1.3

1.6

—

Other and unspecified urticaria

1.58

0.87

1.4

1.6

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

401

1.22

0.87

2.0

1.6

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

2.00

0.87

2.0

1.3

—

Hyperplasia of prostate

188

1.31

0.86

1.3

1.6

—

Medical abortion

160

1.33

0.86

1.6

—

Shoulder lesions

350

1.22

0.86

1.5

1.6

—

Intracranial injury

357

1.27

0.85

1.3

1.5

—

Ethmoidectomy

1.67

0.85

1.2

1.7

—

Benign paroxysmal vertigo

170

1.41

0.85

1.3

1.6

—

Internal derangement of knee

212

1.36

0.84

1.6

1.7

—

Other specified/unspecified bacterial intestinal infections

1.94

0.84

3.0

1.4

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.78

0.84

1.6

—

Use of pramipexole

139

0.58

0.83

1.4

1.6

—

Degeneration of macula and posterior pole

262

1.29

0.82

1.5

1.6

—

Benign neoplasm of middle ear and respiratory system

1.88

0.81

1.2

1.5

—

Endometriosis diagnosis and infertility diagnosis occurring together

1.88

0.81

1.2

1.6

—

Gonarthrosis,primary

431

1.20

0.81

1.5

1.6

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

122

1.36

0.81

1.6

1.8

—

Use of disulfiram, acamprosate or naltrexone

1.70

0.80

1.5

2.0

—

Abscess of anal and rectal regions

1.70

0.80

1.8

1.7

—

Striking against or struck by other objects

189

1.38

0.80

1.7

1.6

—

Type 1 diabetes

130

1.46

0.80

1.3

1.6

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.69

0.80

1.4

1.6

—

Gestational diabetes (for exclusion)

0.51

0.80

1.0

1.9

—

Fitting and adjustment of other devices

176

1.37

0.79

1.3

1.6

—

HSIL lesion of the cervix uteri, vagina or vulva

1.72

0.79

1.7

1.6

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

0.79

0.0

1.8

—

Tubulo-interstitial nephritis, not specified as acute or chronic

1.82

0.79

2.7

1.4

—

Otalgia

1.82

0.79

1.3

1.6

—

Benign neoplasm: Skin, unspecified

0.00

0.79

0.0

1.4

—

Arterial embolism and thrombosis

1.82

0.79

1.3

1.4

—

Type 1 diabetes, strict definition

0.00

0.79

0.0

1.8

—

Other benign neoplasms of skin

233

1.33

0.79

1.6

1.7

—

Haemangioma, any site

1.67

0.78

2.5

1.6

—

Speech and linguistic disorders

0.00

0.78

0.0

1.3

—

Colectomy operation

106

1.51

0.78

1.2

1.6

—

Personality disorders, excluding more controls

106

1.51

0.78

2.3

1.5

—

Foreign body in respiratory tract

0.00

0.78

0.0

1.6

—

Speech and linguistic disorders, excluding more controls

0.00

0.78

0.0

1.4

—

Sleep disorders

1.53

0.78

1.4

1.6

—

Subjective visual disturbances

131

1.45

0.78

1.7

1.5

—

Insomnia

1.62

0.78

1.4

1.6

—

Degenerative macular diseases

1.59

0.78

1.3

1.4

—

0.00

0.77

0.0

1.3

—

Diaphragmatic hernia

234

1.33

0.77

1.5

1.6

—

Diabetic retinopathy, excluding more controls

1.44

0.77

1.6

—

Other abnormal uterine and vaginal bleeding

1.48

0.76

1.8

1.5

—

Other benign neoplasms of connective and other soft tissue

1.77

0.76

1.8

1.7

—

Early lumbar disc prolapse, operated

1.77

0.76

1.7

1.9

—

Early lumbar disc prolapse operation

1.77

0.76

1.7

2.2

—

Benign lipomatous neoplasm of other sites/unspecified

1.77

0.76

1.8

1.5

—

Melanocytic naevi of other and unspecified parts of face

0.00

0.76

0.0

1.4

—

Inguinal hernia

319

1.23

0.75

1.5

1.6

—

Polycystic ovarian syndrome, consortium definition

188

1.28

0.75

1.9

1.5

—

Other/unspecified disorders of vestibular function

2.09

0.74

1.0

1.5

—

Atypical facial pain

2.09

0.74

2.2

1.4

—

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

2.09

0.74

2.2

1.7

—

Other and unspecified visual disturbances

1.67

0.74

1.1

1.4

—

All dysplastic lesions of the cervix uteri

1.60

0.74

1.8

1.5

—

Colorectal adenocarcinoma

135

0.59

0.73

1.3

1.6

—

Excessive, frequent and irregular menstruation

101

1.38

0.72

2.0

1.5

—

Pustular psoriasis

2.00

0.72

1.2

1.5

—

Benign neoplasm: Transverse colon

1.80

0.72

1.4

1.3

—

Spermatocele

1.61

0.72

1.3

1.8

—

Later onset COPD

158

1.34

0.71

1.6

1.5

—

Disorders of conjunctiva

408

1.21

0.71

1.9

1.6

—

Benign neoplasm: Rectum

117

1.45

0.71

1.4

1.6

—

Superficial injury of head

117

1.45

0.71

1.5

1.6

—

Other keratitis

1.58

0.71

1.3

1.7

—

Intestinal stricture

194

1.34

0.71

1.9

1.6

—

Papillary adenocarcinoma of thyroid gland

1.93

0.70

2.2

1.5

—

Nonspecific lymphadenitis

1.92

0.70

1.2

2.1

—

Postprocedural disorders of nervous system

1.92

0.70

1.0

2.1

—

Polycystic ovarian syndrome, broad definition

1.92

0.70

1.4

2.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.54

0.70

1.2

1.5

—

Other peripheral vascular diseases

1.71

0.70

1.6

1.5

—

Bipolar affective disorders

1.53

0.68

2.4

1.6

—

Postmenopausal osteoporosis with pathological fracture

1.85

0.68

2.4

1.3

—

Other local infections of skin and subcutaneous tissue

1.64

0.68

1.7

1.8

—

Psoriatic and enteropathic arthropathies

1.64

0.68

3.1

1.8

—

Astigmatism

1.85

0.68

1.6

1.4

—

Acute gastritis

1.67

0.68

1.4

1.5

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1.59

0.68

1.1

1.7

—

Haemorrhage in early pregnancy

114

0.60

0.67

1.0

1.6

—

391

1.21

0.67

1.4

1.6

—

Pure hypercholesterolaemia

347

1.20

0.67

1.5

1.6

—

Dental caries 1, only avohilmo

315

1.19

0.67

1.6

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

1.64

0.67

1.7

1.5

—

Benign neoplasm of other and unspecified endocrine glands

1.63

0.66

1.7

—

Benign neoplasm: Rectum, anus and anal canal

136

1.40

0.66

1.4

1.6

—

Parkinson's disease, strict definition

0.53

0.66

1.0

1.4

—

Hypertrophic cardiomyopathy

1.79

0.66

1.2

1.5

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

1.79

0.66

1.8

1.3

—

DVT of lower extremities

111

1.44

0.65

1.6

—

Statin medication

285

1.20

0.65

1.6

—

Injuries to the ankle and foot

383

1.21

0.65

1.7

1.6

—

Nail disorders

1.59

0.65

2.4

1.7

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

110

1.44

0.65

1.9

1.6

—

Artrosis, including avohilmo

365

1.17

0.65

1.3

1.7

—

Benzodiazepine use

495

1.16

0.64

1.8

1.6

—

Dental caries 2 and operation codes, only avohilmo

321

0.81

0.64

1.4

1.6

—

Abnormal findings on examination of urine, without diagnosis

1.73

0.64

2.4

1.4

—

Other neurotic disorders

1.73

0.64

1.2

1.4

—

Exposure to other and unspecified inanimate mechanical forces

1.73

0.64

1.0

1.7

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mycobacterium sp identified in Blood by Organism specific culture

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS